Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki

    ... little is known about whether radiation exposure is also a prognostic factor of MDS. We investigated the impact of radiation exposure on ... of MDS in Nagasaki atomic bomb survivors using the International Prognostic Scoring System (IPSS) and the revised version ...

    Research Article last updated 11/02/2016 - 9:24am.

  2. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)

    ... closely associated with lower-risk MDS, defined by the International Prognostic Scoring System (IPSS) and revised IPSS (IPSS-R). IPSS-R could ...

    Research Article last updated 09/19/2016 - 11:07am.

  3. Validation of the revised international prognostic scoring system in treated patients with myelodysplastic syndromes.

    ... 20, 2013 The International Prognostic Scoring System (IPSS) was recently revised (IPSS-R) under the ...

    Research Article last updated 05/14/2013 - 2:50pm.

  4. Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation

    ... survival was independent of the revised International Prognostic Scoring System (IPSS-R). Combining somatic mutations and IPSS-R risk ...

    Research Article last updated 10/06/2016 - 3:00pm.

  5. Current State of the Art: Management of Higher Risk Myelodysplastic Syndromes

    ... myelodysplastic syndrome (MDS) patients, defined by the International Prognostic Scoring System (IPSS) as intermediate-2 or high-risk groups, ...

    Research Article last updated 09/19/2016 - 11:11am.

  6. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes

    ... June 27, 2012 The International Prognostic Scoring Sytem (IPSS) is an important standard for assessing ...

    Research Article last updated 07/29/2014 - 8:54am.

  7. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.

    ... in the United States in 4 cohorts: (1) lower-risk MDS ( International Prognostic Scoring System [IPSS] low and intermediate-1 risk), with and ...

    Research Article last updated 09/19/2016 - 11:05am.

  8. The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system

    ... (MDS) is currently estimated by using the revised International Prognostic Scoring System (IPSS-R). Several studies have shown that ...

    Research Article last updated 12/08/2015 - 1:08pm.

  9. Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

    ... PURPOSE: This international phase III, randomized, placebo -controlled, double-blind ... in RBC transfusion-dependent patients with International Prognostic Scoring System lower-risk non-del(5q) myelodysplastic ...

    Research Article last updated 07/18/2016 - 10:30am.

  10. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes

    ... intermediate-risk disease as classified by the Revised International Prognostic Scoring System (IPSS-R) or those with higher-risk disease for ...

    Research Article last updated 07/18/2016 - 11:26am.